SIA "PANPHARMACY"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedNo dividends were paid.
Summary of financial statements2013–2025
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||||
| Total current assets | 91 557 | 144 333 | 256 579 | 146 441 | 227 373 | 283 467 | 267 611 | 193 296 | 243 734 | 244 913 | 258 216 | 767 505 | 1 561 649 |
| Total non-current assets | 571 | 19 024 | 51 082 | 43 798 | 31 879 | 39 047 | 130 557 | 140 503 | 243 742 | 262 843 | 279 172 | 673 754 | 250 913 |
| Total assets | 92 128 | 163 357 | 307 661 | 190 239 | 259 252 | 322 514 | 398 168 | 333 799 | 487 476 | 507 756 | 537 388 | 1 441 259 | 1 812 562 |
| Balance sheet — liabilities and equity | |||||||||||||
| Current liabilities | 21 785 | 95 044 | 296 658 | 234 972 | 311 751 | 279 596 | 386 354 | 212 119 | 201 349 | 176 776 | 155 201 | 374 743 | 517 239 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 21 785 | 95 044 | 296 658 | 234 972 | 311 751 | 279 596 | 386 354 | 212 119 | 201 349 | 176 776 | 155 201 | 374 743 | 517 239 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 9295 | -31 777 | -19 027 | -55 736 | -7766 | 95 417 | -31 104 | 109 866 | 164 447 | 44 853 | 51 207 | 684 329 | 228 807 |
| Total equity | 70 343 | 68 313 | 11 003 | -44 733 | -52 499 | 42 918 | 11 814 | 121 680 | 286 127 | 330 980 | 382 187 | 1 066 516 | 1 295 323 |
| Income statement | |||||||||||||
| Sales revenue | 493 204 | 741 907 | 748 635 | 1 372 187 | 1 596 069 | 2 313 055 | 2 688 824 | 4 086 312 | 5 647 879 | 5 675 467 | 5 786 320 | 6 497 737 | 9 537 457 |
| Operating profit | 10 326 | -31 999 | -19 055 | -55 736 | -7766 | 95 760 | -31 104 | 110 141 | 164 734 | 44 853 | 51 207 | 664 915 | 191 741 |
| Profit before income tax | 10 953 | -31 777 | -19 027 | -55 736 | -7766 | 95 760 | -31 104 | 110 141 | 164 734 | 44 853 | 51 207 | 684 329 | 228 977 |
| Profit for the reporting year | 9295 | -31 777 | -19 027 | -55 736 | -7766 | 95 417 | -31 104 | 109 866 | 164 447 | 44 853 | 51 207 | 684 329 | 228 807 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||||
| Employees | 1 | 2 | 8 | 8 | 8 | 10 | 12 | 15 | 18 | 18 | 17 | 10 | 10 |
| Calculated dividend | — | 0 | 38 283 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA "PANPHARMACY"
Overview
SIA "PANPHARMACY" (reg. no. 40003355520) is a limited liability company. The company was registered in 1997 and has been in the register for 29 years. Registered address: Mārupes nov., Mārupe, Dzirnieku iela 26.
Financial results
Revenue in 2025 was 9 537 457 €, up 46,8% on the previous year (6 497 737 €). From 2013 to 2025, revenue grew by an average of 28,0% per year. This is the company's highest revenue among the published years (2013–2025). Net profit for 2025 was 228 807 € (2,4% of revenue). The company was profitable in 8 of the 13 published years. In 2025 the company had 10 employees. Revenue per employee was 953 746 €. At the end of 2025, total assets were 1 812 562 € and equity 1 295 323 € (71,5% of assets).
Management and owners
The board has 4 members. The sole owner of the company is AS Oribalt Tallinn.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.